IASO
LIVE

Serial Number

79412638

Owner

Nanjing IASO Biotechnology Co., Ltd.

Attorney

Yue Robert Xu

Filing Date

Nov 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

IASO Trademark

Serial Number: 79412638 • Registration: 8248445

IASO is a trademark filed by Nanjing IASO Biotechnology Co., Ltd. on November 1, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Nanjing IASO Biotechnology Co., Ltd.

10/F, Building D, Zhongdan Ecological Life Science

Entity Type: 98

Trademark Details

Filing Date

November 1, 2024

Registration Date

May 12, 2026

Published for Opposition

October 7, 2025

Goods & Services

Medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in chemotherapy; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; biological preparations for the treatment of tumor; biological preparations for medical purposes, for the treatment of tumor, endocrine, metabolic, central nervous system disorders, autoimmune disorders and blood disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biochemical preparations for medical purposes, for the treatment of tumor, endocrine, metabolic, central nervous system disorders, autoimmune disorders and blood disorders; reagents for use in medical genetic testing; pharmaceutical products for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; medical diagnostic reagents; anti-cancer preparations; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; cytostatics for medical purposes; cells for medical use; antivirals; pharmaceutical preparations for the treatment of immune system related diseases and disorders; yeast extracts for medical, veterinary or pharmaceutical purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 4, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 16, 2026 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 16, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 16, 2025 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 17, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 15, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 31, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2024 REPR